Cargando…
Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives
Substantial efforts are underway for prevention of early stages or recurrence of colorectal cancers (CRC) or new polyp formation by chemoprevention strategies. Several epidemiological, clinical and preclinical studies to date have supported the chemopreventive potentials of several targeted drug cla...
Autores principales: | Mohammed, Altaf, Yarla, Nagendra Sastry, Madka, Venkateshwar, Rao, Chinthalapally V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121559/ https://www.ncbi.nlm.nih.gov/pubmed/30096840 http://dx.doi.org/10.3390/ijms19082332 |
Ejemplares similares
-
Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials
por: Yarla, Nagendra S., et al.
Publicado: (2020) -
Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases
por: Yarla, Nagendra Sastri, et al.
Publicado: (2020) -
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023) -
Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
por: Mohammed, Altaf, et al.
Publicado: (2017) -
Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras(G12V) mice
por: Kumar, Gaurav, et al.
Publicado: (2021)